Who is sponsoring NCT04175548?

NCT04175548 is sponsored by Tamas Illes.

What drugs are being tested in NCT04175548?

Interventions in NCT04175548: Data extraction from medical files.

What condition does NCT04175548 study?

NCT04175548 studies Pertrochanteric Fracture.

Is NCT04175548 still recruiting?

NCT04175548 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04175548

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cut-out of the Cervical Screw on Pertrochanteric Fractures

Completed Last updated 20 July 2022

What this trial tests

trial testing Data extraction from medical files in Pertrochanteric Fracture in 12 participants. Completed in 23 November 2020.

Timeline

13 August 2019

Primary endpoint
23 November 2020

23 November 2020

Quick facts

Lead sponsor	Tamas Illes
Status	Completed
Study type	OBSERVATIONAL
Enrollment	12
Start date	13 August 2019
Primary completion	23 November 2020
Estimated completion	23 November 2020
Sites	1 location across Belgium

Drugs / interventions tested

Data extraction from medical files

Conditions studied

Pertrochanteric Fracture — all drugs for Pertrochanteric Fracture →

Sponsor

Tamas Illes

Who can join

18 and older, any sex, with Pertrochanteric Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pertrochanteric fractures are a highly relevant topic not only because of the high frequency or age of the population concerned, but also because of comorbidity (osteoporosis, malnutrition, decreased physical activity, decreased visual acuity, neurological deficits, asthenia, disorders of the equilibrium and impaired reflexes) and the mortality associated with this type of fractures. The cut-out of the cervical screw is a mechanical complication common to different means of osteosynthesis of pertrochanteric fractures, this complication significantly increases the morbidity. From January 2013 to May 2019, out of a total of 340 patients having had surgery for pertrochanteric fracture, 12 cases of cervical screw cut-out were recorded within the Brugmann University Hospital. The average follow-up after surgery was 18 months. This study analyses different parameters and their link with cervical screw cut-outs, and compares the results with the ones published in the scientific literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Data extraction from medical files

Trials testing the same drug.

NCT04988178 — Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis · completed
NCT04891835 — Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (E · completed
NCT04857099 — Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema · completed
NCT04886908 — Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Year · completed
NCT04770506 — Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria · completed

Other Tamas Illes trials

Trials by the same sponsor.

NCT03460418 — Treatment of Humerus Fractures by a Multiloc Nail, Through a Minimally Invasive Procedure. · completed
NCT03418987 — The Vertebral Vector in a Horizontal Plane. A Simple Way to See in 3D. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04175548 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tamas Illes
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04175548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing